123 related articles for article (PubMed ID: 6487901)
1. Inhibition of vasoconstriction by frusemide in the rat.
Gerkens JF; Smith AJ
Br J Pharmacol; 1984 Oct; 83(2):363-71. PubMed ID: 6487901
[TBL] [Abstract][Full Text] [Related]
2. Frusemide inhibition of sympathetic vasoconstriction in the rat in situ blood perfused mesentery.
Armsworth SJ; Gerkens JF; Smith AJ
Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):495-503. PubMed ID: 3757313
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of frusemide on sympathetic vasoconstrictor responses: dependence on a renal hormone and the vascular endothelium.
Gerkens JF
Clin Exp Pharmacol Physiol; 1987 May; 14(5):371-7. PubMed ID: 3677482
[TBL] [Abstract][Full Text] [Related]
4. Chemical renal medullectomy prevents frusemide-induced inhibition of sympathetic vasoconstriction in the in situ blood perfused rat mesentery.
Gerkens JF; Armsworth SJ; Bhagwandeen SB; Smith AJ
J Hypertens; 1987 Jun; 5(3):273-5. PubMed ID: 3611775
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic constriction of the ex vivo tail artery perfused with blood from rats given frusemide.
Gerkens JF; Armsworth SJ; Smith AJ
Clin Exp Hypertens A; 1987; 9(1):51-79. PubMed ID: 3107857
[TBL] [Abstract][Full Text] [Related]
6. Renal vascular effects of frusemide in the rat: influence of salt loading and the role of angiotensin II.
Dobrowolski L; Badzyńska B; Grzelec-Mojzesowicz M; Sadowski J
Exp Physiol; 2001 Sep; 86(5):611-6. PubMed ID: 11571489
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
Sturrock ND; Lang CC; Coutie WJ; Struthers AD
J Hypertens; 1995 Sep; 13(9):987-91. PubMed ID: 8586834
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
Gerkens JF
Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):161-7. PubMed ID: 2721028
[TBL] [Abstract][Full Text] [Related]
9. Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man.
Motwani JG; Struthers AD
Br J Clin Pharmacol; 1994 Apr; 37(4):355-61. PubMed ID: 8018457
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
11. Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle.
Stanke F; Devillier P; Bréant D; Chavanon O; Sessa C; Bricca G; Bessard G
Br J Clin Pharmacol; 1998 Dec; 46(6):571-5. PubMed ID: 9862246
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent inhibition of sympathetic vasoconstriction by frusemide administration to rats.
Gerkens JF; Armsworth SJ; Dosen PJ; Smith AJ
Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):449-55. PubMed ID: 3271618
[TBL] [Abstract][Full Text] [Related]
13. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
Buckingham RE
Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388
[TBL] [Abstract][Full Text] [Related]
14. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Dupont AG; Lefebvre RA; Vanderniepen P
Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
[TBL] [Abstract][Full Text] [Related]
15. Captopril interferes with neurogenic vasoconstriction in the pithed rat by angiotensin-dependent mechanisms.
Hatton R; Clough DP
J Cardiovasc Pharmacol; 1982; 4(1):116-23. PubMed ID: 6176786
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of captopril on renal responses to frusemide in sodium-restricted rats.
Chiu PJ; Brown AD; Barnett A
J Pharm Pharmacol; 1984 Jan; 36(1):31-5. PubMed ID: 6141260
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
Griffin SA; Brown WC; MacPherson F; McGrath JC; Wilson VG; Korsgaard N; Mulvany MJ; Lever AF
Hypertension; 1991 May; 17(5):626-35. PubMed ID: 2022407
[TBL] [Abstract][Full Text] [Related]
18. Effects of indomethacin, during pregnancy in the rat, on responses to noradrenaline and angiotensin II in vivo, and responses to phenylephrine in vitro.
Jansakul C; King RG; Boura AL
Reprod Fertil Dev; 1990; 2(5):587-90. PubMed ID: 2075253
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the vasoconstrictor activity of indomethacin in the mesenteric vascular bed of the cat.
Lippton HL; Armstead WM; Hyman AL; Kadowitz PJ
Prostaglandins Leukot Med; 1987 Apr; 27(1):81-91. PubMed ID: 3473508
[TBL] [Abstract][Full Text] [Related]
20. Synergistic vascular effects of dietary sodium supplementation and angiotensin II administration.
Csiky B; Simon G
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1275-82. PubMed ID: 9321816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
